Nextar Life Sciences Private Limited - Company Profile

It is a trading private limited company based in Thiruvananthapuram, Kerala, India, established in 2011.

2011 Thiruvananthapuram, Kerala, India Active

Last Updated: January 10, 2026

About Nextar Life Sciences Private Limited

Nextar Life Sciences Private Limited, a active private limited company, was established on 18 February 2011 in Thiruvananthapuram, Kerala, India. Engaging in wholesale within the trade sector, it holds CIN: U52311KL2011PTC027722. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sujith Kumar Sreekantan (Director), Vasanthakumari Madhusoodhanan Pillai Vijith (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Tc 70/2328-2, Uthram, Attukal Manacaud Po, Thiruvananthapuram, Kerala, 695009.

Company Details

CIN/LLPIN
U52311KL2011PTC027722
Registration Number
027722
Incorporation Date
18 February 2011
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Ernakulam
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.10 M as on 10-01-2026
Paid Up Capital ₹ 0.10 M as on 10-01-2026
Company Age 14 Year, 11 Months
Last Filing with ROC 31 Mar 2024

Comprehensive Company Insights

Explore comprehensive insights into Nextar Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Nextar Life Sciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sujith Kumar Sreekantan	Director	18 Feb 2011	Current
Vasanthakumari Madhusoodhanan Pillai Vijith	Director	18 Feb 2011	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nextar Life Sciences.

Nextar Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nextar Life Sciences?

In 2017, Nextar Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nextar Life Sciences?

Unlock and access historical data on people associated with Nextar Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nextar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextar Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nextar Life Sciences

Recent Activity within the Organization

Annual General Meeting

Nextar Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

Nextar Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
31 Mar 2024
Director Appointment

The activity Sujith Kumar Sreekantan was appointed as a Director was appointed as a Director on 18 Feb 2011 & has been associated with this company since 14 years 11 months . was completed.
18 Feb 2011
Director Appointment

Vasanthakumari Madhusoodhanan Pillai Vijith was appointed as a Director was appointed as a Director on 18 Feb 2011 & has been associated with this company since 14 years 11 months . was recorded as a recent event.
18 Feb 2011
Company Incorporation

Progress on Nextar Life Sciences Private Limited was registered on 18 Feb 2011 with Roc Ernakulam & aged 14 years 11 months as per MCA records. was documented.
18 Feb 2011

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Nextar Life Sciences Private Limited?

The CIN of Nextar Life Sciences Private Limited is U52311KL2011PTC027722.

Where is Nextar Life Sciences Private Limited headquartered?

Nextar Life Sciences Private Limited is headquartered at Tc 70/2328-2, Uthram, Attukal Manacaud Po, Thiruvananthapuram, Kerala, 695009.

When was Nextar Life Sciences Private Limited incorporated?

Nextar Life Sciences Private Limited was incorporated on 18 February 2011.

Who are the current directors of Nextar Life Sciences Private Limited?

The current directors of Nextar Life Sciences Private Limited are

What is the primary industry of Nextar Life Sciences Private Limited?

The primary industry of Nextar Life Sciences Private Limited is Trade.

Is Nextar Life Sciences Private Limited a listed company?

Nextar Life Sciences Private Limited is unlisted.

What is the capital structure of Nextar Life Sciences Private Limited?

The authorized capital of Nextar Life Sciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Nextar Life Sciences Private Limited?

The compliance status of Nextar Life Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available